YH, P., Z, W., YS, Z., ZY, W., CW, C., HJ, L., . . . M, X. (2026). Activation of α2-adrenergic receptors as a therapeutic strategy for immune rejection in post-surgery osteosarcoma recurrence treatment. Journal of orthopaedic translation, 56, 101009. https://doi.org/10.1016/j.jot.2025.10.001
Chicago Style (17th ed.) CitationYH, Pei, et al. "Activation of α2-adrenergic Receptors as a Therapeutic Strategy for Immune Rejection in Post-surgery Osteosarcoma Recurrence Treatment." Journal of Orthopaedic Translation 56 (2026): 101009. https://doi.org/10.1016/j.jot.2025.10.001.
MLA (9th ed.) CitationYH, Pei, et al. "Activation of α2-adrenergic Receptors as a Therapeutic Strategy for Immune Rejection in Post-surgery Osteosarcoma Recurrence Treatment." Journal of Orthopaedic Translation, vol. 56, 2026, p. 101009, https://doi.org/10.1016/j.jot.2025.10.001.